Joint meeting with Plant Genome Engineering: From Lab to Field
Precision Engineering of the Genome, Epigenome and Transcriptome
March 8-10, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET*
*Program is in development and subject to change
Joint Meetings
Your registration provides you with access to both the “Precision Engineering of the Genome, Epigenome and Transcriptome” and “Plant Genome Engineering: From Lab to Field” eSymposia events. Use the link below to explore the joint meeting features, including live plenary sessions, On Demand talks, posters, forums, job postings, 1:1 Connect appointments and more. This joint meeting access is designed to facilitate cross-disciplinary insights and collaborations to drive both fields in exciting new directions!
Preferred
(EDT)
Happening
Any Time
Content
Dates
Tracks
Speakers
Showing results 1 - 9 of 9
Monday, March 8, 2021
Welcome and Keynote Address
10:00 AM - 10:40 AM EST
Monday, March 8, 2021Chair
Fyodor Urnov, PhD
University of California, Berkeley
Keynote
Tim Yu, MD, PhD
Boston Children's Hospital
Welcome and Keynote Address
Developing Custom Genetic Therapies
10:00 AM - 10:40 AM EST
Monday, March 8, 2021Speaker
Tim Yu, MD, PhD
Boston Children's Hospital
Welcome and Keynote Address
Engineering of Editors and Epi-Editors
10:40 AM - 1:00 PM EST
Monday, March 8, 2021Co-Chairs
Samuel Sternberg, PhD
Columbia University
Patrick Hsu, PhD
University of California, Berkeley
Engineering of Editors and Epi-Editors
Targeted DNA Integration using CRISPR RNA-Guided Transposases
10:40 AM - 11:05 AM EST
Monday, March 8, 2021Speaker
Samuel Sternberg, PhD
Columbia University
Engineering of Editors and Epi-Editors
[NOT AVAILABLE ON DEMAND] New Editing Technologies
11:05 AM - 11:30 AM EST
Monday, March 8, 2021Speaker
Cecilia Cotta-Ramusino, PhD
Tessera Therapeutics
Engineering of Editors and Epi-Editors
Coffee Break
11:30 AM - 11:40 AM EST
Monday, March 8, 2021Engineering of Editors and Epi-Editors
CRISPR in the Time of COVID
11:40 AM - 12:05 PM EST
Monday, March 8, 2021Speaker
Patrick Hsu, PhD
University of California, Berkeley
Engineering of Editors and Epi-Editors
[NOT AVAILABLE ON DEMAND] Endogenous RNA Editing Systems
12:05 PM - 12:30 PM EST
Monday, March 8, 2021Speaker
Prashant Mali, PhD
University of California, San Diego
Engineering of Editors and Epi-Editors
Short Talk: A Compact Cascade-Cas3 System for Targeted Genome Engineering and Gene Discovery
12:30 PM - 12:45 PM EST
Monday, March 8, 2021Speaker
Balint Csorgo, PhD
UCSF
Engineering of Editors and Epi-Editors
Short Talk: CRISPR-based Multimodal Functional Analysis Reveals the Key Role of Retroviral Sequence LTR7 in Governing Neural Fate Commitment of Human Embryo Development
12:45 PM - 1:00 PM EST
Monday, March 8, 2021Speaker
Yarui Diao, PhD
Duke University School of Medicine
Engineering of Editors and Epi-Editors
[Joint Session] Career Roundtable
2:30 PM - 3:30 PM EST
Monday, March 8, 2021Panelists
Britt Adamson, PhD
Princeton University
Rachel Haurwitz, PhD
Caribou Biosciences, Inc.
Steven Jacobsen, PhD
University of California, Los Angeles
Career Roundtable
Controlling CRISPR
5:00 PM - 8:00 PM EST
Monday, March 8, 2021Co-Chairs
Charles Gersbach, PhD
Duke University
Henriette O'Geen, PhD
University of California, Davis
Controlling CRISPR
Visible and Invisible HDR in Human Cells
5:00 PM - 5:25 PM EST
Monday, March 8, 2021Speaker
Jacob Corn, PhD
ETH Zürich
Controlling CRISPR
Multiplexed Probing of the Impact of Chromatin on Cas9-Induced DSB Repair Pathways
5:25 PM - 5:50 PM EST
Monday, March 8, 2021Speaker
Bas van Steensel, PhD
Netherlands Cancer Institute
Controlling CRISPR
Design of Eukaryotic Gene Regulatory Circuits
5:50 PM - 6:15 PM EST
Monday, March 8, 2021Speaker
Ahmad Khalil, PhD
Boston University
Controlling CRISPR
Coffee Break
6:15 PM - 6:35 PM EST
Monday, March 8, 2021Controlling CRISPR
[NOT AVAILABLE ON DEMAND] Engineering the Repetitive 3D Genome in Human Disease
6:35 PM - 7:00 PM EST
Monday, March 8, 2021Speaker
Jennifer Phillips-Cremins, PhD
University of Pennsylvania
Controlling CRISPR
Short Talk: Strategies to Improve Engineering Cancer Associated SNVs with Base Editing
7:00 PM - 7:15 PM EST
Monday, March 8, 2021Speaker
Alyna Katti, BS
Weill Cornell Medicine
Controlling CRISPR
Short Talk: Unraveling the Transcriptional Impact of DNA Demethylation at Specific Promoters by Targeted Steric Blockage of DNA Methyltransferase with CRISPR/dCas9
7:15 PM - 7:30 PM EST
Monday, March 8, 2021Speaker
Daniel Sapozhnikov, BS
McGill University
Controlling CRISPR
Short Talk: Determinants of Persistence in Epigenetic Editing
7:30 PM - 7:45 PM EST
Monday, March 8, 2021Speaker
Henriette O'Geen, PhD
University of California, Davis
Controlling CRISPR
Short Talk: Programmable Human Histone Phosphorylation and Gene Activation using a CRISPR/Cas9-Based Chromatin Kinase
7:45 PM - 8:00 PM EST
Monday, March 8, 2021Speaker
Isaac Hilton, PhD
Rice University
Controlling CRISPR
Tuesday, March 9, 2021
Therapeutics I: Ex Vivo Editing
10:00 AM - 1:00 PM EST
Tuesday, March 9, 2021Co-Chairs
Rachel Haurwitz, PhD
Caribou Biosciences, Inc.
Nicole Gaudelli, PhD
Beam Therapeutics
Therapeutics I: Ex Vivo Editing
The Future is Allogeneic - Translating a CRISPR Platform into Gene-Edited Cell Therapies
10:00 AM - 10:25 AM EST
Tuesday, March 9, 2021Speaker
Rachel Haurwitz, PhD
Caribou Biosciences, Inc.
Therapeutics I: Ex Vivo Editing
Genome Editing of Blood Cells to Cure Disease
10:25 AM - 10:50 AM EST
Tuesday, March 9, 2021Speaker
Matthew Porteus, MD, PhD
Stanford University School of Medicine
Therapeutics I: Ex Vivo Editing
T-Cell Gene Editing for Cancer Immunotherapy
10:50 AM - 11:15 AM EST
Tuesday, March 9, 2021Speaker
Chiara Bonini, MD
Vita-Salute San Raffaele University
Therapeutics I: Ex Vivo Editing
Coffee Break
11:15 AM - 11:35 AM EST
Tuesday, March 9, 2021Therapeutics I: Ex Vivo Editing
An Adenine Base Editing Strategy for the Treatment of Sickle Cell Disease by Elimination of the Pathogenic Globin Protein
11:35 AM - 12:00 PM EST
Tuesday, March 9, 2021Speaker
Nicole Gaudelli, PhD
Beam Therapeutics
Therapeutics I: Ex Vivo Editing
[NOT AVAILABLE ON DEMAND] Short Talk: Knockout of NKG2A by CRISPR in Human NK Cells Enhance their Cytotoxic Activity Against Solid Tumors
12:00 PM - 12:15 PM EST
Tuesday, March 9, 2021Speaker
Delphine Guipouy, PhD
CHU Sainte Justine Research Center
Therapeutics I: Ex Vivo Editing
Short Talk: Fast and Efficient Generation of TRAC-integrated CAR T Cells without Viruses
12:15 PM - 12:30 PM EST
Tuesday, March 9, 2021Speaker
Dimitrios Wagner, MD
Charité - Universitätsmedizin Berlin
Therapeutics I: Ex Vivo Editing
Short Talk: Optimizing Stem Cell Lines for in vitro-derived Beta Cell Therapeutics via Genome-wide CRISPR Knock-out Screening
12:30 PM - 12:45 PM EST
Tuesday, March 9, 2021Speaker
Adrian Veres, PhD
Harvard University
Therapeutics I: Ex Vivo Editing
Short Talk: Expanding the Scope of Marker-Free Selection for CRISPR-Driven Genome Editing in Human Cells
12:45 PM - 1:00 PM EST
Tuesday, March 9, 2021Speaker
Sébastien Levesque, MS
CHU de Québec - Université Laval
Therapeutics I: Ex Vivo Editing
[Joint Session] Meet the Editors Roundtable
2:30 PM - 3:30 PM EST
Tuesday, March 9, 2021Panelists
Holger Breithaupt, PhD
EMBO Press
Kevin Davies
The CRISPR Journal
Bing Yang
Frontiers in Genome Editing
Ruth Zearfoss, PhD
Cell Reports Methods, Cell Press
Roland Roberts, PhD
PLOS (Public Library of Science)
Caitlin Karniski, PhD
Nature Portfolio
Meet the Editors Roundtable
Therapeutics II: In Vivo Editing
5:00 PM - 7:45 PM EST
Tuesday, March 9, 2021Co-Chairs
Fyodor Urnov, PhD
University of California, Berkeley
Ana Moreno Collado, PhD
Navega Therapeutics
Therapeutics II: In Vivo Editing
Development of crPhage to Treat Infections
5:00 PM - 5:25 PM EST
Tuesday, March 9, 2021Speaker
David Ousterout, PhD
Locus Biosciences, Inc.
Therapeutics II: In Vivo Editing
Towards a CRISPRi/a Therapeutic for Radiation Injury
5:25 PM - 5:50 PM EST
Tuesday, March 9, 2021Speaker
Fyodor Urnov, PhD
University of California, Berkeley
Therapeutics II: In Vivo Editing
Engineering AAV for Targeted In Vivo Editing
5:50 PM - 6:15 PM EST
Tuesday, March 9, 2021Speaker
Aravind Asokan, PhD
Duke University
Delivery
Coffee Break
6:15 PM - 6:35 PM EST
Tuesday, March 9, 2021Therapeutics II: In Vivo Editing
Epigenome Regulation for Treatment of Chronic Pain
6:35 PM - 7:00 PM EST
Tuesday, March 9, 2021Speaker
Ana Moreno Collado, PhD
Navega Therapeutics
Therapeutics II: In Vivo Editing
Short Talk: A Versatile Platform for ADAR-Mediated RNA Editing in vivo in Preclinical Models
7:00 PM - 7:15 PM EST
Tuesday, March 9, 2021Speaker
Chikdu Shivalila, PhD
Wave Life Sciences
Therapeutics II: In Vivo Editing
Short Talk: Upregulation of Disease Compensatory Gene via CRISPR Activation in Muscular Dystrophy Mice
7:15 PM - 7:30 PM EST
Tuesday, March 9, 2021Speaker
Jia Qi Cheng-Zhang, MS
University of Pittsburgh
Therapeutics II: In Vivo Editing
Short Talk: CRISPR Activation to Rescue SCN2A Haploinsufficiency in Autism Spectrum Disorder
7:30 PM - 7:45 PM EST
Tuesday, March 9, 2021Speaker
Serena Tamura, BA
University of California San Francisco
Therapeutics II: In Vivo Editing
Wednesday, March 10, 2021
Delivery
10:00 AM - 12:50 PM EST
Wednesday, March 10, 2021Co-Chairs
Charles Gersbach, PhD
Duke University
Daniel Siegwart, PhD
University of Texas Southwestern Medical Center
Delivery
Selective ORgan Targeting (SORT): A Synthetic Lipid Nanoparticle (LNP) Strategy for Effective Tissue-Specific Genome Engineering
10:00 AM - 10:25 AM EST
Wednesday, March 10, 2021Speaker
Daniel Siegwart, PhD
University of Texas Southwestern Medical Center
Delivery
In Vivo Editing Approaches for Gene Therapy and Functional Genomics
10:25 AM - 10:50 AM EST
Wednesday, March 10, 2021Speaker
Charles Gersbach, PhD
Duke University
Therapeutics II: In Vivo Editing
Delivering Gene Editing Components by Testing Thousands of Nanoparticles in vivo
10:50 AM - 11:15 AM EST
Wednesday, March 10, 2021Speaker
James Dahlman, PhD
Georgia Tech / Emory Medical School
Delivery
Coffee Break
11:15 AM - 11:35 AM EST
Wednesday, March 10, 2021Delivery
Short Talk: Mesenchymal Stem Cell Delivery for Zinc Finger Proteins in Preclinical Animal Models of Angelman Syndrome
11:35 AM - 11:50 AM EST
Wednesday, March 10, 2021Speaker
Peter Deng, PhD
University of California, Davis
Delivery
Short Talk: In Vivo Genome Editing of Hematopoietic Stem and Progenitor Cells using Non-viral Delivery of CRISPR/Cas9
11:50 AM - 12:05 PM EST
Wednesday, March 10, 2021Speaker
Sean Burns, MD
Intellia Therapeutics
Delivery
Short Talk: Broadening PAM Recognition of CRISPR-Associated Endonucleases by Protein Recombination
12:05 PM - 12:20 PM EST
Wednesday, March 10, 2021Speaker
Aaron Lin, PhD
Metagenomi
Delivery
Short Talk: Controllable Genome Editing with Split-Engineered Base Editors
12:20 PM - 12:35 PM EST
Wednesday, March 10, 2021Speaker
Kiara Berrios, BS
University of Pennsylvania
Delivery
Short Talk: CRISPR-mediated Transcriptional Activation and Simultaneous Gene Knockout and Activation with Synthetic Guide RNAs
12:35 PM - 12:50 PM EST
Wednesday, March 10, 2021Speaker
Kevin Hemphill, MS
Horizon Discovery
Delivery
Screening & Single Cell Technologies
5:00 PM - 8:00 PM EST
Wednesday, March 10, 2021Co-Chairs
John Doench, PhD
Broad Institute of MIT and Harvard University
Britt Adamson, PhD
Princeton University
Screening & Single Cell Technologies
Bridging the Variant-to-Function Chasm: Screens with Base Editor Technology
5:00 PM - 5:25 PM EST
Wednesday, March 10, 2021Speaker
John Doench, PhD
Broad Institute of MIT and Harvard University
Screening & Single Cell Technologies
Single Cell Sequencing Technologies
5:25 PM - 5:50 PM EST
Wednesday, March 10, 2021Speaker
Britt Adamson, PhD
Princeton University
Screening & Single Cell Technologies
Predicting the Efficiencies and Outcomes of Genome Editing using Deep Learning
5:50 PM - 6:15 PM EST
Wednesday, March 10, 2021Speaker
Hyongbum Henry Kim, MD, PhD
Yonsei University College of Medicine
Screening & Single Cell Technologies
Coffee Break
6:15 PM - 6:30 PM EST
Wednesday, March 10, 2021Screening & Single Cell Technologies
Genome-Wide Programmable Transcriptional Memory by CRISPR-Based Epigenome Editing
6:30 PM - 6:55 PM EST
Wednesday, March 10, 2021Speaker
Jonathan Weissman, PhD
Whitehead Institute and MIT
Screening & Single Cell Technologies
Short Talk: Functional Interrogation of DNA Damage Response Variants with Base Editing Screens
6:55 PM - 7:10 PM EST
Wednesday, March 10, 2021Speaker
Alberto Ciccia, PhD
Columbia University
Screening & Single Cell Technologies
Short Talk: Harnessing Epigenetic Editing Tools to Identify and Modulate Mechanically-Activated Genomic Enhancers
7:10 PM - 7:25 PM EST
Wednesday, March 10, 2021Speaker
Brian Cosgrove, PhD
Duke University
Screening & Single Cell Technologies
[NOT AVAILABLE ON DEMAND] Short Talk: Toward Genome-Scale Single-Cell Screens with Multi-Modal Perturb-Seq
7:25 PM - 7:40 PM EST
Wednesday, March 10, 2021Speaker
Pratiksha Thakore, PhD
Broad Institute
Screening & Single Cell Technologies
Short Talk: Spear-ATAC: Pooled, Droplet-Based, Single-Cell Chromatin Accessibility CRISPR Screens
7:40 PM - 7:55 PM EST
Wednesday, March 10, 2021Speaker
Sarah Pierce, BS
Stanford University
Screening & Single Cell Technologies
Closing Remarks
7:55 PM - 8:00 PM EST
Wednesday, March 10, 2021Screening & Single Cell Technologies
